Pulse Biosciences (PLSE) closed at $50.44 on November 13, 2026, down 3.5% from the previous close, on volume of 577,843 shares (30-day average 386,626).
Data as of November 13, 2026.
13-Nov-2026
Business Wire (Fri, 6-Nov 7:00 AM ET)
Pulse Biosciences Reports Business Updates and Third Quarter 2026 Financial Results
Business Wire (Thu, 5-Nov 4:05 PM ET)
Pulse Biosciences to Present at Stifel 2026 Healthcare Conference
Business Wire (Thu, 29-Oct 1:05 PM ET)
Business Wire (Thu, 22-Oct 4:05 PM ET)
Pulse Biosciences Announces Commercial and Clinical Partnership with the Clayman Thyroid Center
Business Wire (Wed, 14-Oct 7:00 AM ET)
PLSE discloses inducement grants for 5,700 shares with a $49.98 exercise price
Market Chameleon (Mon, 12-Oct 7:27 AM ET)
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire (Fri, 9-Oct 4:05 PM ET)
PLSE gains as nPulse ventricular arrhythmia work gets an October 2026 VT Symposium spotlight
Market Chameleon (Fri, 9-Oct 7:56 AM ET)
Business Wire (Thu, 8-Oct 7:00 AM ET)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
Pulse Biosciences trades on the NASDAQ stock market under the symbol PLSE.
As of November 13, 2026, PLSE stock price declined to $50.44 with 577,843 million shares trading.
PLSE has a beta of 0.54, meaning it tends to be less sensitive to market movements. PLSE has a correlation of 0.01 to the broad based SPY ETF.
PLSE has a market cap of $3.71 billion. This is considered a Mid Cap stock.
Last quarter Pulse Biosciences reported $395,000 in Revenue and -$.32 earnings per share. This fell short of revenue expectation by $-122,336 and missed earnings estimates by -$.02.
In the last 3 years, PLSE traded as high as $58.94 and as low as $5.22.
The top ETF exchange traded funds that PLSE belongs to (by Net Assets): VTI, IWM, VXF, IWO, SCHA.
PLSE has outperformed the market in the last year with a return of +256.7%, while the SPY ETF gained +13.4%. In the last 3 month period, PLSE beat the market returning +12.3%, while SPY returned -2.8%. However, in the most recent 2 weeks PLSE has underperformed the stock market by returning -3.4%, while SPY returned -0.2%.
PLSE support price is $49.62 and resistance is $54.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PLSE shares will trade within this expected range on the day.
